AURA 3: the last word on chemotherapy as a control arm in EGFR mutant NSCLC?

Ann Transl Med. 2017 May;5(Suppl 1):S14. doi: 10.21037/atm.2017.03.73.

Authors

Terry L Ng¹, D Ross Camidge¹

Affiliation

¹ Division of Medical Oncology, Department of Medicine, University of Colorado and University of Colorado Cancer Center, 1665 North Aurora Court, Aurora, 80045, Colorado, USA.

No abstract available

Publication types

Editorial
Comment